Nick Pavlakis

23PUBLICATIONS
160CO-AUTHORS
Radiation therapyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsChemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Nov 12, 2025
Theranostic Radioembolization: Radiation Dosimetry-Guided Treatment Planning and Delivery.

Dale L Bailey, Elizabeth J Bernard, Richard Maher

|Jun 16, 2025
The Ave-Rec Trial: Phase II Trial of PDL1/PD1 Blockade with Avelumab after Chemoradiotherapy for Locally Advanced Resectable T3B-4/N1-2 Rectal Cancer.

Michael Michael, Rachel Wong, Sanjeev Gill

|Jun 02, 2025
INTEGRATE pooled phase 2/3 results are robust to postprogression switching and the winner's curse.

Yu Yang Soon, Katrin Sjoquist, Ian C Marschner

|Jan 29, 2025
First-Line Mobocertinib Versus Platinum-Based Chemotherapy in Patients With EGFR Exon 20 Insertion-Positive Metastatic Non-Small Cell Lung Cancer in the Phase III EXCLAIM-2 Trial.

Pasi A Jänne, Bin-Chao Wang, Byoung Chul Cho

|Oct 04, 2024
INTEGRATE IIa Phase III Study: Regorafenib for Refractory Advanced Gastric Cancer.

Nick Pavlakis, Kohei Shitara, Katrin Sjoquist

|Aug 06, 2024
A Phase Ib/II Randomized Clinical Trial of Oleclumab with or without Durvalumab plus Chemotherapy in Patients with Metastatic Pancreatic Ductal Adenocarcinoma.

Andrew L Coveler, Matthew J Reilley, Mark Zalupski

Pageof 4

Frequent Collaborators

3 joint publications

Katrin Sjoquist

3 joint publications

Timothy Price

3 joint publications

David Wyld

3 joint publications

Sumit Sahni